<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1688-0420</journal-id>
<journal-title><![CDATA[Revista Uruguaya de Cardiología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev.Urug.Cardiol.]]></abbrev-journal-title>
<issn>1688-0420</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Uruguaya de Cardiología]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1688-04202018000300033</article-id>
<article-id pub-id-type="doi">10.29277/cardio.33.3.6</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Mortalidad y reingreso hospitalario de pacientes con enfermedad coronaria en un seguimiento a cinco años]]></article-title>
<article-title xml:lang="en"><![CDATA[Mortality and hospital readmission of patients with coronary artery disease in a 5-year follow-up]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Burdiat]]></surname>
<given-names><![CDATA[Gérard]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Olalde]]></surname>
<given-names><![CDATA[Carlos]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Tejada]]></surname>
<given-names><![CDATA[Jorge]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Benkel]]></surname>
<given-names><![CDATA[Eduardo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Asociación Española Servicio de Cardiología ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2018</year>
</pub-date>
<volume>33</volume>
<numero>3</numero>
<fpage>33</fpage>
<lpage>63</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_arttext&amp;pid=S1688-04202018000300033&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_abstract&amp;pid=S1688-04202018000300033&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_pdf&amp;pid=S1688-04202018000300033&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Antecedentes:  diversas investigaciones han mostrado que la prevención secundaria en pacientes portadores de cardiopatía isquémica puede influir de manera beneficiosa en la morbimortalidad cardiovascular. Los diferentes estudios reportan resultados que varían en un amplio rango según los objetivos planteados y no contamos con datos al respecto en nuestro medio. En nuestra institución se lleva a cabo un programa de prevención secundaria que incluye a todos los pacientes ingresados por patología coronaria.  Objetivo:  determinar las tasas de reinternación y mortalidad poshospitalaria en pacientes con enfermedad coronaria isquémica participantes de un programa de prevención secundaria y explorar sus causas.  Métodos:  se realizó un estudio observacional y prospectivo sobre la incidencia de readmisiones hospitalarias y muertes ocurridas posinternación de una cohorte de pacientes coronarios, analizando la historia clínica informatizada y el seguimiento telefónico de todos los pacientes, que se realizó por un tiempo promedio de 4,8 años. Se establecieron sus causas y los datos procesados se expresaron en porcentajes, mientras que las diferencias de tasas se analizaron mediante el test de chi cuadrado o prueba t, según correspondiera.  Resultados:  se incluyeron 1.375 pacientes consecutivos con cardiopatía isquémica, edad 68,1 ± 10,0 años (37-80), sexo masculino 72,5%. El síndrome coronario agudo fue la causa de internación inicial en el 71,0% de los casos. Se perdió el seguimiento de 74 pacientes. De los 1.301 pacientes restantes, al cabo del período de seguimiento, 616 (47,3%) fueron reinternados. Se registraron 1.226 nuevos ingresos hospitalarios, siendo la causa un nuevo episodio coronario en 361 (29,4%) de los cuáles 144 (39,9%), recibieron una nueva angioplastia transluminal coronaria y 62 (17,2%) cirugía de revascularización miocárdica (p&gt;0,001). Se destaca que el 79,2% del total de pacientes estuvo libre de nuevos eventos coronarios en todo el período y fueron muy escasas las reinternaciones por nuevas obstrucciones coronarias en el primer año posalta (2,8%). Hubo un total de 107 muertes (7,8% de 1.371 pacientes con datos de mortalidad disponibles), de las cuales 74 fueron de origen cardiovascular (5,4% del total de pacientes) y la mayoría, 45 (60,8%) se produjeron dentro del primer año, p&lt;0,001 vs muerte &gt;1 año. Las causas predominantes de las muertes fueron: muerte súbita (26,2%), infarto agudo de miocardio (22,4%) e insuficiencia cardíaca (13,1%).  Conclusiones: en esta serie consecutiva y no seleccionada de pacientes internados por patología coronaria e ingresados a un programa de prevención secundaria se observaron tasas de reingreso similares a otras publicadas y una mortalidad entre las más bajas reportadas en la literatura. La mayoría de las reinternaciones y muertes sobrevinieron como consecuencia de un evento isquémico, siendo baja la tasa de mortalidad por insuficiencia cardíaca. Es posible que el programa de prevención cardiovascular haya tenido impacto en los resultados observados.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Summary:  Background:  different research has shown that secondary prevention in coronary artery disease patients may beneficially influence on cardiovascular morbidity and mortality. Diverse studies report different results, varying over a wide range according to the objectives and there are no data about our environment. At our institution, a secondary prevention program that includes all patients admitted for a coronary disease takes place.  Purpose:  to determine the rehospitalization and post-hospital mortality rates in patients with coronary disease participating in a secondary prevention program and to explore their causes.  Methods:  an observational and prospective study about the incidence of hospital readmissions and deaths in a cohort of post-hospital coronary patients was performed by analyzing the computerized clinical history and telephone follow-up of all patients, which was performed for a mean time of 4.8 years. Their causes were established, and processed data are expressed as percentages, while the rate differences were analyzed using the chi test or t test as appropriate.  Results:  one thousand three hundred and seventy-five consecutive ischemic heart disease patients were included, age 68.1 ± 10.0 years (37-80), 72.5% male. Acute coronary syndrome was the cause of hospitalization in 71.0% of cases. The follow-up of 74 patients was lost. Of the remaining 1.301 patients, at the end of the follow-up period, 616 (47.3%) patients were readmitted. There were 1.226 new hospital readmissions, due to a new coronary episode in 361 (29.4%) of which 144 (39.9%) received a new coronary transluminal angioplasty and 62 (17.2%) myocardial revascularization surgery (p&gt; 0.001). The highlight was that 79.2% of the total number of patients was free of new coronary events throughout the whole period and coronary readmissions were very scarce in the first year after hospital discharge (2.8%). Regarding the deaths, there were 107 (7.8% of 1.371 patients with available mortality data), of which 74 were cardiovascular origin (5.4%) and the majority, 45 (60.8%) occurred within the first year (p&lt;0.001 vs. death &gt;1 year). Sudden death (26.2%), acute myocardial infarction (22.4%) and heart failure (13.1%) were predominant causes.  Conclusions:  in this consecutive and unselected series of patients hospitalized for coronary disease included in a secondary prevention program, readmission rates were similar to those published and mortality was among the lowest reported in the literature. Most readmissions and deaths occurred due to an ischemic event, and the mortality rate due to heart failure was low. It is possible that the cardiovascular prevention program has had an impact on the observed results.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Enfermedad coronaria]]></kwd>
<kwd lng="es"><![CDATA[Isquemia miocárdica]]></kwd>
<kwd lng="es"><![CDATA[Indicadores de morbimortalidad]]></kwd>
<kwd lng="es"><![CDATA[Prevención secundaria]]></kwd>
<kwd lng="es"><![CDATA[Readmisión del paciente]]></kwd>
<kwd lng="en"><![CDATA[Coronary disease]]></kwd>
<kwd lng="en"><![CDATA[Myocardial ischemia]]></kwd>
<kwd lng="en"><![CDATA[Indicators of morbidity and mortality]]></kwd>
<kwd lng="en"><![CDATA[Secondary prevention]]></kwd>
<kwd lng="en"><![CDATA[Patient readmission]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<collab>Organización Mundial de la Salud</collab>
<source><![CDATA[Enfermedades cardiovasculares.Datos y cifras]]></source>
<year>2017</year>
<publisher-loc><![CDATA[Ginebra ]]></publisher-loc>
<publisher-name><![CDATA[OMS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Normand]]></surname>
<given-names><![CDATA[SLT]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Drye]]></surname>
<given-names><![CDATA[EE]]></given-names>
</name>
<name>
<surname><![CDATA[Schreiner]]></surname>
<given-names><![CDATA[GC]]></given-names>
</name>
<name>
<surname><![CDATA[Krumholz]]></surname>
<given-names><![CDATA[HM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Recent declines in hospitalizations for acute myocardial infarction for Medicare fee-for-service beneficiaries progress and continuing challenges]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2010</year>
<volume>121</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1322-8</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[De Velasco]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Llargués]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Fitó]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Sala]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Del Río]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia de los factores de riesgo y tratamiento farmacológico al alta hospitalaria en el paciente coronario Resultados de un registro multicéntrico nacional (Programa 3C)]]></article-title>
<collab>De los Arcos E</collab>
<source><![CDATA[Rev Esp Cardiol]]></source>
<year>2001</year>
<volume>54</volume>
<numero>02</numero>
<issue>02</issue>
<page-range>159-68</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[De Velasco]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Cosin]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[López-Sendón]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[de Teresa]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[de Oya]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Sellers]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nuevos datos sobre la prevención secundaria del infarto de miocardio en España Resultados del estudio PREVESE II]]></article-title>
<source><![CDATA[Rev Esp Cardiol]]></source>
<year>2002</year>
<volume>55</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>801-9</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rosamond]]></surname>
<given-names><![CDATA[WD]]></given-names>
</name>
<name>
<surname><![CDATA[Chambless]]></surname>
<given-names><![CDATA[LE]]></given-names>
</name>
<name>
<surname><![CDATA[Heiss]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Mosley]]></surname>
<given-names><![CDATA[TH]]></given-names>
</name>
<name>
<surname><![CDATA[Coresh]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Whitsel]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Twenty-Two-Year trends in incidence of myocardial infarction, coronary heart disease mortality, and case fatality in 4 US communities, 1987-2008]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2012</year>
<volume>125</volume>
<numero>15</numero>
<issue>15</issue>
<page-range>1848-57</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fiscella]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Meldrum]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Barnett]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hospital discharge against advice after myocardial infarction deaths and readmissions]]></article-title>
<source><![CDATA[Am J Med]]></source>
<year>2007</year>
<volume>120</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1047-53</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<collab>Task Force Members: Montalescot G.Sechtem U.Achenbach S.Andreotti F.Arden C.Budaj AESC Committee for Practice Guidelines</collab>
<article-title xml:lang=""><![CDATA[2013 ESC guidelines on the management of stable coronary artery disease the Task Force on the management of stable coronary artery disease of the European Society of Cardiology]]></article-title>
<source><![CDATA[Eur Heart J]]></source>
<year>2013</year>
<volume>34</volume>
<numero>38</numero>
<issue>38</issue>
<page-range>2949-3003</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Boden]]></surname>
<given-names><![CDATA[WE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Optimal medical therapy with or without PCI for stable coronary disease]]></article-title>
<collab>O'Rourke RA.Teo KK.Hartigan PM.Maron DJ.Kostuk WJ.for the COURAGE Trial Research Group</collab>
<source><![CDATA[N Eng J Med]]></source>
<year>2007</year>
<volume>356</volume>
<numero>15</numero>
<issue>15</issue>
<page-range>1503-16</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gagliardi]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[De Abreu]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mariani]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Silberstein]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[De Sagastizábal]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
<name>
<surname><![CDATA[Salzberg]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Motivos de ingreso, procedimientos, evolución y terapéutica al alta de 54 000 pacientes ingresados a unidades de cuidados intensivos cardiovasculares en la Argentina. Seis años del Registro Epi-Cardio]]></article-title>
<source><![CDATA[Rev Argent Cardiol]]></source>
<year>2012</year>
<volume>80</volume>
<page-range>446-54</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Coto Valldeperas]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Gutiérrez Jaikel]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Resultados clínicos y complicaciones de la angioplastia coronaria con stent en el Hospital México (Costa Rica) en el período 2005-2007]]></article-title>
<source><![CDATA[Rev Costarr Cardiol]]></source>
<year>2009</year>
<volume>11</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>13-9</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aguiar AAFd]]></surname>
</name>
<name>
<surname><![CDATA[Mourilhe-Rocha]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Esporcatte]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Amorin]]></surname>
<given-names><![CDATA[LC]]></given-names>
</name>
<name>
<surname><![CDATA[Tura]]></surname>
<given-names><![CDATA[BR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Análisis a largo plazo en el síndrome coronario agudo ¿Existen diferencias de morbimortalidad? (Versión en español)]]></article-title>
<collab>Albuquerque DCd</collab>
<source><![CDATA[Arq Bras Cardiol]]></source>
<year>2010</year>
<volume>95</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>705-12</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Navia]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Vaccarino]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Vrancic]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Piccinini]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Iparraguirre]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Albertal]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Resultado terapéutico de la cirugía coronaria Analisis de la evolución alejada. Estudio SEGUIR]]></article-title>
<source><![CDATA[Rev Argent Cardiol]]></source>
<year>2003</year>
<volume>71</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>275-81</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dussaillant]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Dighero]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Pumarino]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Delgado]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Cumsille]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Resultados alejados de la angioplastia coronaria en Chile en el Registro Nacional de Angioplastia Coronaria (RENAC) 2001-2002]]></article-title>
<source><![CDATA[Rev Chil Cardiol]]></source>
<year>2006</year>
<volume>25</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>121-5</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bradshaw]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Jamrozik]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Le]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gilfillan]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Thompson]]></surname>
<given-names><![CDATA[PL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mortality and recurrent cardiac events after coronary artery bypass graft long term outcomes in a population study]]></article-title>
<source><![CDATA[Heart]]></source>
<year>2002</year>
<volume>88</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>488-94</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Serruys]]></surname>
<given-names><![CDATA[PW]]></given-names>
</name>
<name>
<surname><![CDATA[Ong]]></surname>
<given-names><![CDATA[AT]]></given-names>
</name>
<name>
<surname><![CDATA[van Herwerden]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Sousa]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Jatene]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bonnier]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease The final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial]]></article-title>
<source><![CDATA[J Am Coll Cardiol]]></source>
<year>2005</year>
<volume>46</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>575-81</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moreno-Palanco]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Ibáñez-Sanz]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Ciria-de-Pablo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Pizarro-Portillo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez Salvanés]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Suárez-Fernández]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Impacto de un tratamiento integral e intensivo de factores de riesgo sobre la mortalidad cardiovascular en prevención secundaria estudio MIRVAS]]></article-title>
<source><![CDATA[Rev Esp Cardiol]]></source>
<year>2011</year>
<volume>64</volume>
<numero>03</numero>
<issue>03</issue>
<page-range>179-85</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Iestra]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Kromhout]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effect size estimates of lifestyle and dietary changes on all-cause mortality in coronary artery disease patients A systematic review]]></article-title>
<collab>van der Schouw YT.Grobbee DE.Boshuizen HC.van Staveren WA</collab>
<source><![CDATA[Circulation]]></source>
<year>2005</year>
<volume>112</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>924-34</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Andrés]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Cordero]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Magán]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Alegría]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[León]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Luengo]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mortalidad a largo plazo y reingreso hospitalario tras infarto agudo de miocardio un estudio de seguimiento de ocho años]]></article-title>
<source><![CDATA[Rev Esp Cardiol]]></source>
<year>2012</year>
<volume>65</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>414-20</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rapsomaniki]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Thuresson]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Blin]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Hunt]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Using big data from health records from four countries to evaluate chronic disease outcomes a study in 114 364 survivors of myocardial infarction]]></article-title>
<collab>Chung SC et al</collab>
<source><![CDATA[Eur Heart J Qual Care Clin Outcomes]]></source>
<year>2016</year>
<volume>2</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>172-83</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Riera]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Herrero]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ibáñez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Campillo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Amézaga]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Supervivencia a medio plazo de los pacientes operados en cirugía cardíaca mayor]]></article-title>
<collab>Sáez de Ibarra JI</collab>
<source><![CDATA[Rev Esp Cardiol]]></source>
<year>2011</year>
<volume>64</volume>
<numero>06</numero>
<issue>06</issue>
<page-range>463-9</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Weintraub]]></surname>
<given-names><![CDATA[WS]]></given-names>
</name>
<name>
<surname><![CDATA[Grau-Sepúlveda]]></surname>
<given-names><![CDATA[MV]]></given-names>
</name>
<name>
<surname><![CDATA[Weiss]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[DeLong]]></surname>
<given-names><![CDATA[ER]]></given-names>
</name>
<name>
<surname><![CDATA[De Peterson]]></surname>
<given-names><![CDATA[ED]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prediction of long-term mortality after percutaneous coronary intervention in older adults Results from the National Cardiovascular Data Registry]]></article-title>
<collab>O'Brien SM</collab>
<source><![CDATA[Circulation]]></source>
<year>2012</year>
<volume>125</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1501-10</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="confpro">
<source><![CDATA[Hemingway H, on behalf of the APOLLO investigators. Up to 4 years after AMI, 17.2% of patients suffer a second event]]></source>
<year></year>
<conf-name><![CDATA[ ESC Congress]]></conf-name>
<conf-date>2014</conf-date>
<conf-loc>Barcelona, Spain </conf-loc>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Putignano]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Fedele di Maio]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Orlando]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[De Nicola]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Menditto]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<source><![CDATA[Cost analysis of an Intensive Care Unit]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cooper]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Linde-Zwirble]]></surname>
<given-names><![CDATA[WT]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medicare Intensive Care Unit use analysis of incidence, cost, and payment]]></article-title>
<source><![CDATA[Crit Care Med]]></source>
<year>2004</year>
<volume>32</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>2247-53</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Piepoli]]></surname>
<given-names><![CDATA[MF]]></given-names>
</name>
<name>
<surname><![CDATA[Hoes]]></surname>
<given-names><![CDATA[AH]]></given-names>
</name>
<name>
<surname><![CDATA[Agewall]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Albus]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Brotons]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Catapano]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guía ESC 2016 sobre prevención cardiovascular en la práctica clínica]]></article-title>
<source><![CDATA[Rev Esp Cardiol]]></source>
<year>2016</year>
<volume>69</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>939e81-7</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Benjamin]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
<name>
<surname><![CDATA[Bonow]]></surname>
<given-names><![CDATA[RO]]></given-names>
</name>
<name>
<surname><![CDATA[Braun]]></surname>
<given-names><![CDATA[LT]]></given-names>
</name>
<name>
<surname><![CDATA[Creajer]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Franklin]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[AHA/ACCF Secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease 2011 Update. A Guideline From the American Heart Association and American College of Cardiology Foundation]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2011</year>
<volume>124</volume>
<numero>22</numero>
<issue>22</issue>
<page-range>2458-73</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
